| Literature DB >> 21941551 |
Rania M Khashaba1, Mervet Moussa, Christopher Koch, Arthur R Jurgensen, David M Missimer, Ronny L Rutherford, Norman B Chutkan, James L Borke.
Abstract
Aim. Physicochemical mechanical and in vitro biological properties of novel formulations ofEntities:
Year: 2011 PMID: 21941551 PMCID: PMC3176494 DOI: 10.1155/2011/467641
Source DB: PubMed Journal: Int J Biomater ISSN: 1687-8787
Materials used in this study and their manufacturers.
| Material | Composition | Trade Name | Manufacturers |
|---|---|---|---|
| (1) Zinc polycarboxylate cement | Powder: Zinc oxide with traces of Mg oxide and Sn oxide. | G.C.R. | Advanced Research IncDental division England |
| (2) Glass Ionomer liquid light cured modified polyalkenoic acid | A light sensitive aqueous solution of polyalkenoic acid modified with methacrylic group. | Vitremer | 3M Dental products St. Louis, USA |
| (3) Monocalcium phosphate monobasic (MCPM) | Calcium Phosphate Monobasic | Sigma Chemical Co., Aldrich GmbhGermany | |
| (4) Calcium oxide (CaO) | Adwic Laboratory Chemical | ||
| (5) Polymethyl vinyl ether maleic anhydrate copolymer (white powder) PMVE-Ma | Sigma-chemical Laboratories St. Louis, USA | ||
| (6) Synthetic hydroxylapatite (SHAP6) | Prepared at the Department of Dental Materials of the Medical College of Georgia, Augusta, Ga, USA |
The initial setting time (in minutes) of zinc polycarboxylate cement and the three polymeric calcium phosphate cements (CPCs).
| Zinc polycarboxylate (control group) | Polymeric calcium phosphate | L.S.D.5% | |||
|---|---|---|---|---|---|
| Type I | Type II | Type II | |||
| Mean setting time (in minutes) ± SD | 5 ± 1 | 5 ± 1 | — | 9 ± 1 | 1.30* |
NB: Type II polymeric CPC (no setting reaction) VLC type.
*Significant at 5% level.
Mean compressive strength and standard deviation of zinc polycarboxylate cement and the three polymeric calcium phosphate cements (CPCs) in MPa.
| Cement types | 1 hour | 24 hours | 1 week | 4 weeks | 8 weeks |
| |
|---|---|---|---|---|---|---|---|
| Control zinc polycarboxylate | 46.85 ± 3.51 | 50.83 ± 4.50 | 50.87 ± 2.65 | 51.88 ± 2.80 | 52.60 ± 2.95 | 4.33* | |
| Calcium phosphate cements (CPCs) | Type I | 40.42 ± 3.33 | 44.87 ± 3.25 | 49.80 ± 2.75 | 48.74 ± 2.80 | 46.91 ± 3.65 | 3.90* |
| Type II | 66.86 ± 1.38 | 67.13 ± 1.30 | 67.15 ± 1.38 | 67.20 ± 1.30 | 67.12 ± 1.22 | 1.74* | |
| Type III | 71.68 ± 3.15 | 75.12 ± 3.55 | 75.56 ± 2.75 | 73.62 ± 2.95 | 73.59 ± 3.10 | 4.09* | |
| LSD 5% | 3.81* | 4.22* | 3.19* | 3.30* | 3.32* | ||
*Significant at 5% level.
Mean diametral tensile strength and standard deviation of zinc polycarboxylate cement and the three polymeric calcium phosphate cements (CPCs) in MPa.
| Cement types | 1 hour | 24 hours | 1 week | 4 weeks | 8 weeks |
| |
|---|---|---|---|---|---|---|---|
| Control zinc polycarboxylate | 5.65 ± 1.91 | 5.92 ± 2.35 | 4.49 ± 1.91 | 5.50 ± 1.99 | 4.80 ± 1.51 | 2.55* | |
| Calcium phosphate cements (CPCs) | Type I | 4.70 ± 1.84 | 5.85 ± 2.41 | 6.41 ± 2.04 | 5.55 ± 2.36 | 4.58 ± 1.84 | 2.77* |
| Type II | 7.39 ± 1.99 | 8.74 ± 1.74 | 8.80 ± 2.02 | 8.63 ± 2.51 | 8.57 ± 2.96 | 2.96* | |
| Type III | 11.43 ± 2.37 | 13.81 ± 2.22 | 14.03 ± 1.95 | 12.77 ± 1.89 | 12.59 ± 1.57 | 3.66* | |
*Significant at 5 % level.
Figure 1Histogram showing the mean compressive strength of zinc polycarboxylate cement and the three polymeric CPCs in MPa.
Figure 2Histogram showing the mean diametral strength of zinc polycarboxylate cement and the three polymeric CPCs in MPa.
Figure 3(A) Zinc polycarboxylate cement; (B) Type I; (C) Type II; (D) Type III. For all cements tested, IR spectra of polymeric acids (modified polyacrylic acid, modified polyalkenoic acid, 35% w/w aqueous solution of PMVE-Ma (a) showed the absorption bands of carboxylic group (C=O) between 1635 to 1640 cm−1 cm (arrows). IR spectra of set cements (b) showed the absorption bands between 1558 and 1401 cm−1 indicating the formation of carboxylic salts (arrows).
Figure 4(a) X-ray diffraction pattern of unreacted zinc polycarboxylate powder. (b) X-ray diffraction pattern of set zinc polycarboxylate cement.
Figure 5X-ray diffraction pattern of the three types of polymeric cements (Type I, Type II, and Type III CPCs). (A) Unreacted powder component. (B) Set product of Type I cement. (C) Set product of Type II cement. (D) Set product of Type III cement. Different arrows indicating the characteristic peaks of the different crystalline phases of the X-ray diffraction pattern; cross-hatched arrows indicate the crystal phase of calcium hydrogen phosphate hydrate, black arrows portlandite, grey arrows hydroxyapatite, and gradient arrows calcite.
Figure 6SEM microphotograph of the longitudinal top surface of the four types of cements. (a) Zinc polycarboxylate cement; (b) Type I; (c) Type II; (d) Type III after setting.
Figure 7SEM microphotograph of the fractured surface of the four types of cements. (a) Zinc polycarboxylate cement; (b) Type I; (c) Type II; (d) Type III after setting.
Figure 8Mitochondrial suppression induced by zinc polycarboxylate, Type I, Type II, and Type III calcium phosphate cements as function of aging time. Cytotoxicity was measured by succinic dehydrogenase activity and expressed as a percentage of Teflon controls (defined as 100%). There were six replicates per condition. Different letters indicate a statistically significant difference between the materials (ANOVA, Tukey intervals α = 0.05).